Berlin, Germany

Michael Klotzbuecher


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Gynecological Treatments: The Contributions of Michael Klotzbuecher

Introduction

Michael Klotzbuecher, an inventive mind residing in Berlin, Germany, has made significant contributions to the field of pharmaceuticals, particularly in gynecological treatments. With a focus on non-steroidal progestins, Klotzbuecher's innovative work reflects the advancements in hormone therapy and contraceptive methods.

Latest Patents

Klotzbuecher holds a patent for a groundbreaking invention titled "Non-steroidal progesting." This patent covers non-steroidal progestins characterized by a specific general formula. These compounds are designed to selectively modulate progesterone receptor-mediated effects in various target tissues, specifically differentiating between uterine and breast tissues. The applicability of these progestins extends to contraception, especially as an option for estrogen-free oral contraceptives, hormone replacement therapy, and treatments for gynecological disorders. Moreover, the patent includes methodologies for selectively modulating effects in different tissues or organs.

Career Highlights

Michael Klotzbuecher is associated with Bayer Schering Pharma AG, a prominent pharmaceutical company, where he has further developed his expertise in hormone therapy. His career is highlighted not only by his patent but also by his commitment to advancing women's health through innovative solutions.

Collaborations

Klotzbuecher has collaborated with notable colleagues such as Norbert Schmees and Manfred Lehmann, enhancing the research and development processes within Bayer Schering Pharma AG. These collaborations underscore the importance of teamwork in advancing scientific research and innovation.

Conclusion

In conclusion, Michael Klotzbuecher's work exemplifies the impact that innovative thinking can have on medicine and public health. His patent for non-steroidal progestins demonstrates the potential for enhanced treatment options in gynecology, making significant strides toward improving women's health solutions. As research continues in this vital area, Klotzbuecher's contributions will remain influential in shaping future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…